𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia

✍ Scribed by Elin Lindhagen; Anna Eriksson; Malin Wickström; Katarina Danielsson; Birgitta Grundmark; Roger Henriksson; Peter Nygren; Anna Åleskog; Rolf Larsson; Martin Höglund

Book ID
114794449
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
388 KB
Volume
81
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib, a selective EGFR tyrosine kin
Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells
✍ Hiroshi Ariyama; Baoli Qin; Eishi Baba; Risa Tanaka; Kenji Mitsugi; Mine Harada; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

## Abstract Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been clinically demonstrated to be effective for certain cancer cell types, the molecular mechanisms of the anti‐tumor activity have not been fully elucidated. In this study, we inv

The MEK/MAPK pathway is involved in the
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
✍ Nicola Normanno; Antonella De Luca; Monica R. Maiello; Manuela Campiglio; Maria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

## Abstract We investigated the role of the MEK/MAPK pathway in the sensitivity/resistance of breast carcinoma cells to the EGFR tyrosine kinase inhibitor gefitinib (IRESSA). We assessed the effects of gefitinib on the growth of three breast cancer cell lines that showed high (SK‐Br‐3; IC~50~ 4 µM)